Rose is a managing editor at The American Journal of Managed Care® (AJMC®).
She has a BA in journalism & media studies and Spanish from Rutgers University. You can connect with Rose on LinkedIn.
Study Using Novel Index Links OSA Severity to Higher Cardiovascular Disease Risk
January 29th 2022Patients in upper quartiles of the sleep breathing impairment index, a novel gauge of obstructive sleep apnea (OSA) severity, had higher 10-year Framingham cardiovascular risk than patients whose symptoms were classified as less severe.
Read More
Severe Daytime Sleepiness Linked With Parkinsonian-Like Symptoms, Study Finds
January 22nd 2022The severity of excessive daytime sleepiness correlated with the prevalence of Parkinsonian-like symptoms in adults aged 50 to 64, but further research is needed to determine the mechanisms behind the findings.
Read More
Understanding Real-World Trends in MRD Testing as Part of MM Management
January 18th 2022An abstract presented at the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition assessed real-world data on patients with multiple myeloma to provide insight into longitudinal testing patterns and rates of sustained minimal residual disease (MRD) negativity.
Read More
AI-Based Anomaly Detection Holds Promise in Screening for Retinal Diseases, Study Says
January 17th 2022Recent findings suggest that with more research, anomaly detection may be an option for general retinal disease screening and identification of novel presentations of common retinal diseases.
Read More
MRD Kinetics Identify High-risk CLL in Study of Zanubrutinib, Venetoclax, Obinutuzumab
January 16th 2022An abstract presented at the 63rd American Society of Hematology Meeting & Exposition found that the regimen was effective and that MRD could potentially be used as a biomarker to inform treatment duration.
Read More
Increased Patient-Physician Dialogue in EDs May Reduce Polypharmacy in Older Patients
January 8th 2022A Danish study observed emergency department (ED) health care providers and identified 5 factors that could play into patient involvement in medication discussions, particularly in older patients with polypharmacy.
Read More
Could GLP-1 RAs Improve COVID-19-Induced Pulmonary Arterial Hypertension?
December 30th 2021Recent studies show that glucagon-like peptide-1 receptor agonists have anti-inflammatory effects in human and rodent pathological models, making them a potential therapeutic strategy for treating pulmonary arterial hypertension after COVID-19 infection.
Read More
Scoliosis Surgery for Pediatric SMA1 Comes With Serious Complications, Study Says
December 11th 2021A case series of corrective surgeries in children with severe scoliosis due to spinal muscular atrophy (SMA) type 1 showed a positive success rate, but with significant postoperative complications.
Read More
Pediatric Patients With ASMD Show Significant Improvement in Olipudase Alfa Trial
December 4th 2021Findings from the single-arm, open-label ASCEND-Peds trial suggest olipudase alfa is well-tolerated and may lead to clinically meaningful improvements in patients with acid sphingomyelinase deficiency (ASMD) who do not have neurovisceral manifestations.
Read More
Pilot Program Underscores Importance of Newborn Screening to Identify, Treat SMA
December 2nd 2021Testing for spinal muscular atrophy in an Australian newborn screening program identified patients across socioeconomic and cultural demographics, mitigating inequity and providing patients with access to multidisciplinary treatment.
Read More